WILMINGTON, Del.—Amalgam Rx, Inc., a Digital Therapeutics and Patient Support company, announced the hiring of a new president, Chris Bergstrom, former partner and head of digital therapeutics at Boston Consulting Group, and the appointment of Sonny Vu, serial entrepreneur, chief executive officer of AREVO, and former founder of Misfit to its Board of Directors.
Vu will be joining Ryan Sysko and Jeff Courtney on the Board of Directors.
“Amalgam Rx is an experienced operator, not only building great products but launching them on a global scale. It is an opportune time for the addition of these accomplished voices to contribute to our growth as we reimagine patient care,” said Ryan Sysko, chief executive officer and founder of Amalgam Rx.
“I’m honored to join this talented team as Digital Health hits a universal inflection point. Amalgam Rx brings the best end-to-end experience to take our partners from concept to multinational commercialization. Amalgam’s modular platform empowers leading life sciences companies to support patients living with any disease, in any regulated environment,” said Chris Bergstrom, newly appointed president of Amalgam Rx.
“I’ve known the Amalgam leadership team for nearly two decades. They were the first to bring a life sciences model to the software industry; they’re truly the pioneers of digital therapeutics. We’re in an unprecedented time with respect to the investment in and growth of digital solutions in healthcare. Amalgam is poised to lead the industry,” said Sonny Vu, newly appointed director of Amalgam Rx.
